Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extensively Drug-resistant Tuberculosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01222338
What this trial is testing

Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients

Who this might be right for
Tuberculosis
Lisichansk Regional Tuberculosis Dispensary 123
Not applicableStudy completedNCT02170441
What this trial is testing

Global Consortium for Drug-resistant Tuberculosis Diagnostics

Who this might be right for
TuberculosisTuberculosis, Multidrug-Resistant
University of California, San Diego 1,128
Large-scale testing (Phase 3)Study completedNCT01061593
What this trial is testing

Adjunct Immunotherapy With Immunoxel in Patients With TB and TB/HIV

Who this might be right for
TuberculosisHIV
Lisichansk Regional Tuberculosis Dispensary 269
Early research (Phase 1)Study completedNCT04309656
What this trial is testing

Single-dose Study in Two Panels of Healthy Adult Participants to Assess Immediate-Release and Dispersible Formulations of Pretomanid

Who this might be right for
Multi-drug Resistant Tuberculosis
Global Alliance for TB Drug Development 48
Not applicableStudy completedNCT02454738
What this trial is testing

Ultralow Dose Computed Tomography in High-risk Drug-resistant Tuberculosis Contacts

Who this might be right for
Latent Tuberculosis
Seoul National University Hospital 6
Large-scale testing (Phase 3)UnknownNCT04081077
What this trial is testing

PRACTECAL-PKPD Sub Study

Who this might be right for
Multi-drug Resistant TuberculosisExtensively Drug-Resistant TuberculosisPulmonary Tuberculosis
Medecins Sans Frontieres, Netherlands 240
Testing effectiveness (Phase 2)Study completedNCT00664313
What this trial is testing

TBTC Study 30: Safety and Tolerability of Low Dose Linezolid in MDR TB

Who this might be right for
Multi-drug Resistant TuberculosisExtensively Drug Resistant Tuberculosis
Centers for Disease Control and Prevention 36
Not applicableStudy completedNCT03162107
What this trial is testing

Promoting Engagement in the Drug Resistant TB/HIV Care Continuum in South Africa

Who this might be right for
Patient Non-compliance
Centre for the AIDS Programme of Research in South Africa 199
Large-scale testing (Phase 3)Study completedNCT02333799
What this trial is testing

Trial Assessing Safety and Efficacy of B-Pa-L in Participants With DR-TB

Who this might be right for
Pulmonary Tuberculosis
Global Alliance for TB Drug Development 109
Not applicableEnded earlyNCT01381757
What this trial is testing

Utility of MODS for Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali

Who this might be right for
Tuberculosis, PulmonaryMycobacterium TuberculousAntitubercular Agents+3 more
National Institute of Allergy and Infectious Diseases (NIAID) 34
Not applicableStudy completedNCT05175794
What this trial is testing

Triage Test for All Oral DR-TB Regimen (TRiAD Study)

Who this might be right for
Drug Resistant TuberculosisMDR-TBXDR-TB+1 more
Centre for the AIDS Programme of Research in South Africa 786
Large-scale testing (Phase 3)Study completedNCT03086486
What this trial is testing

Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR+4 more
Global Alliance for TB Drug Development 181
Not applicableApproved For MarketingNCT01464762
What this trial is testing

Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
Janssen Infectious Diseases BVBA
Large-scale testing (Phase 3)Looking for participantsNCT05081401
What this trial is testing

Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)

Who this might be right for
Multidrug Resistant TuberculosisRifampicin Resistant TuberculosisPre-XDR-TB
Huashan Hospital 1,050